Search Results

You searched for : DrReddys  

Novartis India Limited signs exclusive sales and distribution agreement with Dr. Reddy’s Laboratories

...
Feb 14

Dr. Reddy’s Laboratories Announces Commercial Launch of 2DG

2-DG is yet another addition to our COVID-19 portfolio that already covers the full spectrum of mild to moderate and severe conditions and ...
Jun 28

Dr. Reddy’s Laboratories Announces Commercial Launch of 2DG

2-DG is yet another addition to our COVID-19 portfolio that already covers the full spectrum of mild to moderate and severe conditions and ...
Jun 28

Dr. Reddy's Laboratories announces the launch of Icosapent Ethyl Capsules, 1 gram in the U.S. Market

Dr. Reddy’s Icosapent Ethyl is available in 1 gram capsules in bottle count size of 120’s count....
Jun 22

Dr Reddy's granted approval for 3rd stage Human Trials from DCGI : Russian Sputnik V vaccine

Sputnik V phase 3 trials cleared by the government...
Jan 16

Dr. Reddy's, Global Response Aid, and Appili Therapeutics announce the filing of an application for REEQONUS Tablets

...
Dec 22

Dr. Reddy's and RDIF commence clinical trials for Sputnik V vaccine in India

This will be a multicenter and randomized controlled study, which will include a safety and immunogenicity study....
Dec 02

Dr Reddy’s buys select anti-allergy brands from Glenmark in Russia and other CIS countries

Glenmark to launch Ryaltris, their global anti-allergy brand, in Russia and other CIS countries after the divestment ...
Nov 30

Reddy's partners with Department of Biotechnology for Sputnik V vaccine clinical trials in India

...
Oct 29

Dr. Reddy’s announces the re-launch of OTC Famotidine Tablets USP, store-brand equivalent of Pepcid AC in the U.S. Market

...
Oct 20

Dr. Reddy’s Laboratories joins Science Based Targets initiative and sets 2030 GHG emission targets

Dr. Reddy’s Laboratories Ltd. has joined the SBTi becoming the first Indian and the third Asian pharma company to further minimize environmental impact...
Oct 05

Dr Reddy's seeks approval for 3rd stage Human Trials from DCGI : Russian Sputnik V vaccine

Dr Reddy's is the official partner for the Russian vaccine in India...
Oct 03

Dr. Reddy's announces launch of a generic version of Sapropterin Dihydrochloride Tablets in the U.S. Market

Dr. Reddy’s Laboratories Ltd. today announced the launch of a generic version of Sapropterin Dihydrochloride Tablets, for Oral Use. ...
Oct 03

Dr. Reddy's announces launch of a generic version of Sapropterin Dihydrochloride Tablets in the U.S. Market

Dr. Reddy’s Laboratories Ltd. today announced the launch of a generic version of Sapropterin Dihydrochloride Tablets, for Oral Use. ...
Oct 03

Dr. Reddy's Laboratories announces the launch of Cinacalcet Tablets in the U.S. Market

Dr. Reddy’s Laboratories Ltd., today announced the launch of Cinacalcet Tablets, a generic version of Sensipar Tablets, approved by the USFDA...
Oct 01

Dr. Reddy's announces launch of Dexmedetomidine Hydrochloride in the U.S. Market

...
Sep 25

Dr Reddy's posts Q3 results as per IFRS

Strong Q3 numbers for Dr Reddy's...
Jan 30

Dr. Reddy’s confirms its voluntary nationwide recall of all Ranitidine products in the U.S. Market

...
Oct 24

18 Matching result(s) found!

-Advertisements-




Trending Now

Under 15 Children Under Threat: The TB Comeback No One Saw Coming April 04, 2025
MGM Healthcare Performs World's First Modified Multi-Visceral Transplant for Rare Intestinal DisorderApril 04, 2025
World Health Day 2025: St. George’s University’s Role in Preparing Doctors to Tackle Global Health ChallengesApril 04, 2025
Strength Doesn’t Retire: The Science Behind Ageless PowerApril 04, 2025
Beyond the Baby Bump: Can Delayed Pregnancy Increase Autism Risk in ChildrenApril 04, 2025
University of Manchester invites applications for MA Social AnthropologyApril 03, 2025
Ahead of World Health Day, Sova Health Launches Advanced Microbiome Tests & Evidence-Based Precision Supplements April 03, 2025
Half of women cannot make decisions about their reproductive health and bodily autonomyApril 03, 2025
UGRO CAPITAL LIMITED PUBLIC ISSUE OF SECURED, RATED, LISTED, REDEEMABLE, NON-CONVERTIBLE DEBENTURES (SECURED NCDS) OPENS TODAY EFFECTIVE ANNUALIZED YIELD UP TO 11.01% PER ANNUM* April 03, 2025
SF Airlines Entrusts Çelebi India with Freighter Handling at Kempegowda International Airport, BengaluruApril 03, 2025
Is This the Future of Physiotherapy? Inside Stance Health’s $1M ExpansionApril 03, 2025
The Daily Shower Debate: Are You Washing Away Your Skin’s Health?April 03, 2025
The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025